Kevin Casey, MD
Vascular Surgery · Santa Barbara, CANPI 1487844304
Payments from drug & device makers
Across 201 payments — averaging $151.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$14K
- Medtronic$7K
- W. L. Gore & Associates, Inc.$3K
- Silk Road Medical, Inc.$2K
- Cook Medical LLC$1K
- Bolton Medical Inc$628
- plus $2K from 14 others
What the payments were for
- Consulting fees$3001%
- Speaking & faculty fees$13,37544%
- Travel & lodging$7,44524%
- Food & beverage$9,36131%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $14,368 |
| Medtronic(2 entities) | 70 | $7,430 |
| W. L. Gore & Associates, Inc. | 21 | $2,895 |
| Silk Road Medical, Inc. | 20 | $2,297 |
| Cook Medical LLC | 13 | $1,120 |
| Bolton Medical Inc | 7 | $628 |
| Philips North America LLC | 11 | $422 |
| Bard Peripheral Vascular, Inc. | 7 | $314 |
| Integra Lifesciences Corporation | 3 | $223 |
| Endologix LLC | 1 | $163 |
| Lemaitre Vascular, Inc. | 8 | $107 |
| Cardiva Medical, Inc. | 1 | $96 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Tactile Systems Technology Inc | 4 | $68 |
| Boston Scientific | 3 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| Haemonetics Corporation | 1 | $51 |
| Acell, Inc. | 1 | $48 |
| Teleflex LLC | 1 | $23 |
| Inspiremd Ltd | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$14,045
- IN.PACT Admiral$3,931
- ENROUTE Transcarotid Neuroprotection System$2,264
- GORE TAG Conformable Thoracic Endoprosthesis$1,814
- ENHANCE Transcarotid Peripheral Access Kit$1,372
- ENROUTE Transcarotid Stent System$1,242
- ENROUTE 0.014 Guidewire$1,242
- Valiant Captivia$848
- ENROUTE Transcarotid Stent$690
- Endurant$558
- Cook Medical AAA$441
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$332
- ENDURANT IIS$296
- Cook Medical AFEN$215
- GORE TAG Thoracic Endoprosthesis$188
- Alto Abdominal Stent Graft System$163
- TREO ABDOMINAL STENT-GRAFT SYSTEM$150
- GORE TAG Thoracic Branch Endoprosthesis$148
- VenaSeal$148
- OMNIGRAFT$147
How this compares
$30,489 in reported general payments places this provider in the 80th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 87 | $88,060 |
| EliquisApixaban | 44 | $33,778 |
| ClopidogrelClopidogrel Bisulfate | 84 | $704 |
| Cilostazol | 12 | $128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $14,368 | $88,06087 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 519 vascular surgery providers in California.
Other vascular surgery in Santa Barbara
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
- Bernardo Curi MendesLos Angeles$376K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.